{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:39:56Z","timestamp":1792593596719,"version":"4.5.0"},"reference-count":25,"publisher":"MyJove Corporation","issue":"227","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/70000","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:01:03Z","timestamp":1768953663000},"source":"Crossref","is-referenced-by-count":0,"title":["Intranasal Delivery of mRNA Polyplexes via Rayleigh Breakup Aerosols: An <em>In Vitro<\/em> Method for Nasal Deposition and Functional Testing"],"prefix":"10.3791","author":[{"given":"Mazen","family":"Kafienah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s43856-025-00818-6","type":"journal-article","article-title":"Effect of heterologous intranasal incovacc(r) vaccination as a booster to two-dose intramuscular COVID-19 vaccination series: a randomized phase 3 clinical trial","volume":"5","author":"Akula","year":"2025","unstructured":"Akula, V. R. et al. Effect of heterologous intranasal incovacc(r) vaccination as a booster to two-dose intramuscular COVID-19 vaccination series: a randomized phase 3 clinical trial. Commun Med (Lond). 5 (1), 133 (2025).","journal-title":"Commun Med (Lond)"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","DOI":"10.1063\/1.3524533","type":"journal-article","article-title":"Breakup of diminutive Rayleigh jets","volume":"22","author":"Van Hoeve","year":"2010","unstructured":"Van Hoeve, W. et al. Breakup of diminutive Rayleigh jets. Phys Fluids. 22 (12) (2010).","journal-title":"Phys Fluids"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"125335","DOI":"10.1016\/j.ijpharm.2025.125335","type":"journal-article","article-title":"Targeted nasal delivery of LNP-mRNAs aerosolised by Rayleigh breakup technology","volume":"672","author":"Li","year":"2025","unstructured":"Li, H. Y. et al. Targeted nasal delivery of LNP-mRNAs aerosolised by Rayleigh breakup technology. Int J Pharm. 672, 125335 (2025).","journal-title":"Int J Pharm"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"107651","DOI":"10.1016\/j.jddst.2025.107651","type":"journal-article","article-title":"Rayleigh-based soft mist inhalers preserve mRNA-LNP integrity for pulmonary delivery","volume":"115","author":"He","year":"2026","unstructured":"He, P. et al. Rayleigh-based soft mist inhalers preserve mRNA-LNP integrity for pulmonary delivery. J Drug Deliv Sci Technol. 115, 107651 (2026).","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"107300","DOI":"10.1016\/j.ejps.2025.107300","type":"journal-article","article-title":"Soft mist inhaler nebulization by Rayleigh-breakup largely preserves functional integrity of liposomal mRNA in respirable aerosols","volume":"214","author":"Biesel","year":"2025","unstructured":"Biesel, A. et al. Soft mist inhaler nebulization by Rayleigh-breakup largely preserves functional integrity of liposomal mRNA in respirable aerosols. Eur J Pharm Sci. 214, 107300 (2025).","journal-title":"Eur J Pharm Sci"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1007\/s11095-022-03388-7","type":"journal-article","article-title":"In vitro regional deposition of nasal sprays in an idealized nasal inlet: comparison with in vivo gamma scintigraphy","volume":"39","author":"Chen","year":"2022","unstructured":"Chen, J. Z., Finlay, W. H., Martin, A. In vitro regional deposition of nasal sprays in an idealized nasal inlet: comparison with in vivo gamma scintigraphy. Pharm Res. 39 (11), 3021-3028 (2022).","journal-title":"Pharm Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"119341","DOI":"10.1016\/j.ijpharm.2020.119341","type":"journal-article","article-title":"In vitro assessment of an idealized nose for nasal spray testing: comparison with regional deposition in realistic nasal replicas","volume":"582","author":"Chen","year":"2020","unstructured":"Chen, J. Z., Kiaee, M., Martin, A. R., Finlay, W. H. In vitro assessment of an idealized nose for nasal spray testing: comparison with regional deposition in realistic nasal replicas. Int J Pharm. 582, 119341 (2020).","journal-title":"Int J Pharm"},{"key":"ref8","type":"book","article-title":"Fine Particles in Medicine and Pharmacy","volume-title":"Fine Particles in Medicine and Pharmacy","author":"Hopke","year":"2012","unstructured":"Hopke, P. K., Wang, Z. Fine Particles in Medicine and Pharmacy. In Fine Particles in Medicine and Pharmacy. Springer US, Boston, MA (2012)."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"126084","DOI":"10.1016\/j.ijpharm.2025.126084","type":"journal-article","article-title":"Evaluation of Rayleigh jet atomizer for intranasal delivery of lipid nanoparticle-siRNA formulations: stability, deposition, and device performance","volume":"683","author":"Wang","year":"2025","unstructured":"Wang, H. et al. Evaluation of Rayleigh jet atomizer for intranasal delivery of lipid nanoparticle-siRNA formulations: stability, deposition, and device performance. Int J Pharm. 683, 126084 (2025).","journal-title":"Int J Pharm"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/s41565-025-01961-w","type":"journal-article","article-title":"Compact polyethylenimine-complexed mRNA vaccines","volume":"20","author":"Moreno Herrero","year":"2025","unstructured":"Moreno Herrero, J. et al. Compact polyethylenimine-complexed mRNA vaccines. Nat Nanotechnol. 20 (9), 1323-1331 (2025).","journal-title":"Nat Nanotechnol"},{"issue":"36","key":"ref11","doi-asserted-by":"crossref","first-page":"14604","DOI":"10.1073\/pnas.1209367109","type":"journal-article","article-title":"Non-viral delivery of self-amplifying RNA vaccines","volume":"109","author":"Geall","year":"2012","unstructured":"Geall, A. J. et al. Non-viral delivery of self-amplifying RNA vaccines. Proc Natl Acad Sci U S A. 109 (36), 14604-14609 (2012).","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/mco2.101","type":"journal-article","article-title":"Nasally inhaled therapeutics and vaccination for COVID-19: developments and challenges","volume":"2","author":"Xi","year":"2021","unstructured":"Xi, J., Lei, L. R., Zouzas, W., Si, X. A. Nasally inhaled therapeutics and vaccination for COVID-19: developments and challenges. MedComm. 2 (4), 569-586 (2021).","journal-title":"MedComm"},{"key":"ref13","volume-title":"Zetasizer Advance Series User Guide","year":"2023","unstructured":"Malvern Panalytical. Zetasizer Advance Series User Guide. MAN0592-15-EN edn. Malvern Panalytical (2023).","type":"book"},{"key":"ref14","article-title":"Method of aerosolizing nanoparticle formulations","volume-title":"China patent","author":"Chen","year":"2023","unstructured":"Chen, X., Li, Y., Zhang, Z. Method of aerosolizing nanoparticle formulations. China patent CN116723892A (2023)."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jconrel.2023.09.001","type":"journal-article","article-title":"Polyethylenimine (PEI) in gene therapy: current status and clinical applications","volume":"362","author":"Casper","year":"2023","unstructured":"Casper, J. et al. Polyethylenimine (PEI) in gene therapy: current status and clinical applications. J Control Release. 362, 667-691 (2023).","journal-title":"J Control Release"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","DOI":"10.1063\/5.0163935","type":"journal-article","article-title":"A novel experimental approach to measure nebulized droplet deposition pattern and deposition fraction in an idealized mouth-to-throat model","volume":"35","author":"Jin","year":"2023","unstructured":"Jin, Y. et al. A novel experimental approach to measure nebulized droplet deposition pattern and deposition fraction in an idealized mouth-to-throat model. Phys Fluids. 35 (8) (2023).","journal-title":"Phys Fluids"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/jamp.2011.0916","type":"journal-article","article-title":"Aerosol deposition in health and disease","volume":"25","author":"Darquenne","year":"2012","unstructured":"Darquenne, C. Aerosol deposition in health and disease. J Aerosol Med Pulm Drug Deliv. 25 (3), 140-147 (2012).","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"8025","key":"ref18","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41586-024-07729-x","type":"journal-article","article-title":"Turbinate-homing IgA-secreting cells originate in the nasal lymphoid tissues","volume":"632","author":"Liu","year":"2024","unstructured":"Liu, J. et al. Turbinate-homing IgA-secreting cells originate in the nasal lymphoid tissues. Nature. 632 (8025), 637-646 (2024).","journal-title":"Nature"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jconrel.2010.09.007","type":"journal-article","article-title":"Delivery of messenger RNA using poly(ethylene imine)-poly(ethylene glycol)-copolymer blends for polyplex formation: biophysical characterization and in vitro transfection properties","volume":"148","author":"Debus","year":"2010","unstructured":"Debus, H., Baumhof, P., Probst, J., Kissel, T. Delivery of messenger RNA using poly(ethylene imine)-poly(ethylene glycol)-copolymer blends for polyplex formation: biophysical characterization and in vitro transfection properties. J Control Release. 148 (3), 334-343 (2010).","journal-title":"J Control Release"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1164\/rccm.201011-1783OC","type":"journal-article","article-title":"Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways","volume":"183","author":"Brandtzaeg","year":"2011","unstructured":"Brandtzaeg, P. Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways. Am J Respir Crit Care Med. 183 (12), 1595-1604 (2011).","journal-title":"Am J Respir Crit Care Med"},{"key":"ref21","type":"journal-article","article-title":"Lipid nanoparticles for the delivery of CRISPR\/Cas9 machinery to enable site-specific integration of CFTR and mutation-agnostic disease rescue","author":"Foley","year":"2025","unstructured":"Foley, R. A. et al. Lipid nanoparticles for the delivery of CRISPR\/Cas9 machinery to enable site-specific integration of CFTR and mutation-agnostic disease rescue. bioRxiv. (2025).","journal-title":"bioRxiv"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","type":"journal-article","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R., Dong, Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 6 (12), 1078-1094 (2021).","journal-title":"Nat Rev Mater"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1089\/jamp.2017.1364","type":"journal-article","article-title":"Hybrid lipid\/polymer nanoparticles for pulmonary delivery of siRNA: development and fate upon in vitro deposition on the human epithelial airway barrier","volume":"31","author":"D'Angelo","year":"2018","unstructured":"D'Angelo, I. et al. Hybrid lipid\/polymer nanoparticles for pulmonary delivery of siRNA: development and fate upon in vitro deposition on the human epithelial airway barrier. J Aerosol Med Pulm Drug Deliv. 31 (3), 170-181 (2018).","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"12920","DOI":"10.1038\/s41598-018-31332-6","type":"journal-article","article-title":"Multilayered cultures of NSCLC cells grown at the air-liquid interface allow the efficacy testing of inhaled anti-cancer drugs","volume":"8","author":"Movia","year":"2018","unstructured":"Movia, D., Bazou, D., Volkov, Y., Prina-Mello, A. Multilayered cultures of NSCLC cells grown at the air-liquid interface allow the efficacy testing of inhaled anti-cancer drugs. Sci Rep. 8 (1), 12920 (2018).","journal-title":"Sci Rep"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"P21","DOI":"10.1186\/2045-7022-4-S2-P21","type":"journal-article","article-title":"Characterisation and culture of primary human nasal epithelial cells and the influence of interferon-gamma","volume":"4","author":"Waltl","year":"2014","unstructured":"Waltl, E., Eckl-Dorna, J., Selb, R., Valenta, R., Niederberger, V. Characterisation and culture of primary human nasal epithelial cells and the influence of interferon-gamma. Clin Transl Allergy. 4 (2), P21 (2014).","journal-title":"Clin Transl Allergy"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/70000\/intranasal-delivery-mrna-polyplexes-via-rayleigh-breakup-aerosols-an","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:50:32Z","timestamp":1792590632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/70000\/intranasal-delivery-mrna-polyplexes-via-rayleigh-breakup-aerosols-an"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":25,"journal-issue":{"issue":"227","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/70000","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]}}}